Flow cytometry analysis of primary AML and MDS blast cells revealed three distinct subpopulations (i.e., LSPCs, CMPs, and MBCs), distinguished by the expression of CD34 and CD38 surface markers (Supplementary Fig. 1a). The gene discussed is CD34; the disease is myelodysplastic syndrome.